I didn't say it did. I said if DCVax-L is approved Cognate's buyout will swing back to proving benefit to NWBO. You may not know this, but approval requires demonstrating manufacturing readiness. Ramping commercialization thereafter has everything to do with manufacturing competence/capability/capacity/backing.